Evidence map›Paper›PMID 26397992›Full record

Trial reportAnnals of the American Thoracic Society2015

Comparisons and Limitations of Current Definitions of Bronchopulmonary Dysplasia for the Prematurity and Respiratory Outcomes Program.

Brenda B Poindexter, Rui Feng, Barbara Schmidt, Judy L Aschner, Roberta A Ballard, Aaron Hamvas, Anne Marie Reynolds, Pamela A Shaw, Alan H Jobe, Prematurity and Respiratory Outcomes Program

3 registry-linked trialsOpen access · greenAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Annals of the American Thoracic Society, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 135 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
135citing papers in PubMed, 5 pooled it
21.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01435187 completednot on this map

Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol

TypeobservationalSponsorUniversity of PennsylvaniaRan2011 to 2016Enrolled835ConditionsPrematurity, Respiratory Disease
NCT04184648 completednot on this mapstarted 2020, after this paper: background citation

Clinical Study on Comparative Diagnostic Criteria of Bronchopulmonary Dysplasia in Premature Infants

TypeobservationalSponsorWang JianhuiRan2020 to 2022Enrolled322ConditionsBronchopulmonary DysplasiaArmsno interventions
NCT04237844 unknown statusnot on this mapstarted 2020, after this paper: background citation

Clinic Features and Long-term Outcome of Different Subgroups of Brochopulmonary Dysplasia in Preterm Infants

TypeobservationalSponsorWang JianhuiRan2020 to 2021Enrolled300ConditionsBronchopulmonary Dysplasia
3 · Its place in the literature

Who cites it

135 citing papers in PubMed, 5 syntheses or guidelines pooled it, 273 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Randomised trial of azithromycin to eradicateArchives of disease in childhood. Fetal and neonatal edition · 2020
    Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

75 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 9 institutions in 1 country.

Brenda B Poindexter1 Perinatal Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Rui Feng3 Department of Biostatistics and Epidemiology, and.
Barbara Schmidt4 Division of Neonatology, Children's Hospital of Philadelphia, the Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Judy L Aschner5 Department of Pediatrics, Albert Einstein College of Medicine and the Children's Hospital at Montefiore, Bronx, New York.
Roberta A Ballard7 Department of Pediatrics, University of California at San Francisco School of Medicine, San Francisco, California.
Aaron Hamvas8 Ann & Robert H. Lurie Children's Hospital, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Anne Marie Reynolds10 Department of Pediatrics, University of Buffalo, The State University of New York, Buffalo, New York.
Pamela A Shaw3 Department of Biostatistics and Epidemiology, and.
Alan H Jobe1 Perinatal Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Prematurity and Respiratory Outcomes Program
California University of Pennsylvania · USCancer Research And Biostatistics · USChildren's Hospital at Montefiore · USCincinnati Children's Hospital Medical Center · USIndiana University School of MedicineLurie Children's Hospital · USUniversity at Buffalo, State University of New York · USUniversity of California, San Francisco · USUniversity of Pennsylvania · US

Funding

Data Coordinating Center for the Prematurity and Respiratory Outcomes ProgramU01HL101794 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI SCHMIDT, BARBARA · 2010 to 2014
$10.3M
Gastrin-Releasing Peptide and Bronchopulmonary DysplasiaR01HL105702 · NHLBI · DUKE UNIVERSITY · PI COTTEN, CHARLES MICHAEL, DAVIS, STEPHANIE DUGGINS · 2011 to 2015
$2.8M
Biomarkers of Immunologic Function and Preterm Respiratory OutcomesU01HL101800 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI CHOUGNET, CLAIRE A., JOBE, ALAN H · 2010 to 2014
$2.5M
Functional and Lymphocytic Markers of Respiratory Morbidity in Hyperoxic PreemiesU01HL101813 · NHLBI · UNIVERSITY OF ROCHESTER · PI MARIANI, THOMAS J, PRYHUBER, GLORIA S · 2010 to 2014
$2.4M
Improving Prematurity-related Respiratory Outcomes at Vanderbilt (IMPROV)U01HL101456 · NHLBI · VANDERBILT UNIVERSITY · PI ASCHNER, JUDY LYNN · 2010 to 2014
$2.4M
UCSF Clinical Research Center for Prematurity and Respiratory Outcomes ProgramU01HL101798 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BALLARD, PHILIP L., KELLER, ROBERTA L · 2010 to 2014
$2.1M
Influence of the Enteric Microbiome on the Genesis of Bronchopulmonary DysplasiaU01HL101465 · NHLBI · WASHINGTON UNIVERSITY · PI FERKOL, THOMAS W, WARNER, BARBARA B · 2010 to 2014
$2.1M
CD8 T Cell Dysregulation in Premature InfantsK08AI108870 · NIAID · UNIVERSITY OF ROCHESTER · PI SCHEIBLE, KRISTIN · 2014 to 2016
$539k
NHLBI NIH HHS 5R01 HL105702NHLBI NIH HHS R01 HL105702NHLBI NIH HHS U01 HL101456NHLBI NIH HHS U01 HL101465NHLBI NIH HHS U01 HL101794NHLBI NIH HHS U01 HL101798NHLBI NIH HHS U01 HL101800NHLBI NIH HHS U01 HL101813NIAID NIH HHS K08 AI108870
6 · The paper itself

Abstract

rationaleBronchopulmonary dysplasia is the most common morbidity of prematurity, but the validity and utility of commonly used definitions have been questioned.

objectivesTo compare three commonly used definitions of bronchopulmonary dysplasia in a contemporary prospective, multicenter observational cohort of extremely preterm infants.

methodsAt 36 weeks postmenstrual age, the following definitions of bronchopulmonary dysplasia were applied to surviving infants with and without imputation: need for supplemental oxygen (Shennan definition), National Institutes of Health Workshop definition, and "physiologic" definition after a room-air challenge. MEASUREMENTS AND MAIN

resultsOf 765 survivors assessed at 36 weeks, bronchopulmonary dysplasia was diagnosed in 40.8, 58.6, and 32.0% of infants, respectively, with the Shennan, workshop and physiologic definitions. The number of unclassified infants was lowest with the workshop definition (2.1%) and highest with the physiologic definition (16.1%). After assigning infants discharged home in room air before 36 weeks as no bronchopulmonary dysplasia, the modified Shennan definition compared favorably to the workshop definition, with 2.9% unclassified infants. Newer management strategies with nasal cannula flows up to 4 L/min or more and 0.21 FiO2 at 36 weeks obscured classification of bronchopulmonary dysplasia status in 12.4% of infants.

conclusionsExisting definitions of bronchopulmonary dysplasia differ with respect to ease of data collection and number of unclassifiable cases. Contemporary changes in management of infants, such as use of high-flow nasal cannula, limit application of existing definitions and may result in misclassification. A contemporary definition of bronchopulmonary dysplasia that correlates with respiratory morbidity in childhood is needed. Clinical trial registered with www.clinicaltrials.gov (NCT01435187).

Indexed as

Disease ManagementBronchopulmonary DysplasiaFemaleFollow-Up StudiesHumansInfant, Extremely PrematureInfant, NewbornInfant, Premature, DiseasesMaleMorbidityOxygen Inhalation TherapyPrognosisProgram EvaluationProspective StudiesSurvival RateUnited Statesbronchopulmonary dysplasiainfantneonatal lung diseaseoxygen inhalation therapypremature

Identifiers

PMID26397992
PMCPMC4722827
OpenAlexW2097146460

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.